CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [***]

This Amendment No. 3 (“Amendment”) is effective as of January 1, 2017, and is entered into by and between Daicel Corporation (“Daicel”) and Rayonier A.M. Sales and Technology Inc. (“RYAM”). Daicel and RYAM are each referred to individually herein as a “Party”, and collectively as “Parties”.

WHEREAS, Daicel and RYAM are parties to that certain Amended and Restated Cellulose Specialties Agreement, with an effective date of January 1, 2012, as amended by that certain Amendment No. 1 to Daicel-Rayonier Amended Chemical Specialties Agreement dated as of February 15, 2013 and that certain Amendment No. 2 to Daicel-Rayonier Amended Chemical Specialties Agreement dated as of January 1, 2016 (collectively, the “Agreement”);

WHEREAS, Daicel received [***];

WHEREAS, as provided for in [***] of the Agreement, Daicel and RYAM [***]; and

WHEREAS, [***] and now desire to enter into this Amendment No. 3 for the purposes of memorializing their agreements with respect thereto and of amending certain other terms and provisions of the Agreement.

NOW THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged and agreed, the Parties hereby amend the Agreement as follows:

*[***]

**[***]

For the sake of clarity, the [***] shall be [***], and the [***] shall be treated as [***] for the purpose [***].

The [***] shall consist of [***] and shall for all other intents and purposes be treated the same as [***].

[***].

[***]:

[***].

[***].